Literature DB >> 25899507

Clostridium difficile infection among hospitalized HIV-infected individuals: epidemiology and risk factors: results from a case-control study (2002-2013).

Stefano Di Bella1, Alexander W Friedrich2, Esther García-Almodóvar3, Maria Serena Gallone4, Fabrizio Taglietti5, Simone Topino6, Vincenzo Galati7, Emma Johnson8, Silvia D'Arezzo9, Nicola Petrosillo10.   

Abstract

BACKGROUND: HIV infection is a risk factor for Clostridium difficile infection (CDI) yet the immune deficiency predisposing to CDI is not well understood, despite an increasing incidence of CDI among such individuals. We aimed to estimate the incidence and to evaluate the risk factors of CDI among an HIV cohort in Italy.
METHODS: We conducted a retrospective case-control (1:2) study. Clinical records of HIV inpatients admitted to the National Institute for Infectious Disease "L. Spallanzani", Rome, were reviewed (2002-2013). CASES: HIV inpatients with HO-HCFA CDI, and controls: HIV inpatients without CDI, were matched by gender and age. Logistic regression was used to identify risk factors associated with CDI.
RESULTS: We found 79 CDI episodes (5.1 per 1000 HIV hospital admissions, 3.4 per 10000 HIV patient-days). The mean age of cases was 46 years. At univariate analysis factors associated with CDI included: antimycobacterial drug exposure, treatment for Pneumocystis pneumonia, acid suppressant exposure, previous hospitalization, antibiotic exposure, low CD4 cell count, high Charlson score, low creatinine, low albumin and low gammaglobulin level. Using multivariate analysis, lower gammaglobulin level and low serum albumin at admission were independently associated with CDI among HIV-infected patients.
CONCLUSIONS: Low gammaglobulin and low albumin levels at admission are associated with an increased risk of developing CDI. A deficiency in humoral immunity appears to play a major role in the development of CDI. The potential protective role of albumin warrants further investigation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25899507      PMCID: PMC4408587          DOI: 10.1186/s12879-015-0932-x

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


  37 in total

1.  Bacterial diarrhea in HIV-infected patients: why Clostridium difficile, and why now?

Authors:  Sumathi Sivapalasingam; Martin J Blaser
Journal:  Clin Infect Dis       Date:  2005-10-31       Impact factor: 9.079

Review 2.  Clostridium difficile--more difficult than ever.

Authors:  Ciarán P Kelly; J Thomas LaMont
Journal:  N Engl J Med       Date:  2008-10-30       Impact factor: 91.245

3.  Bacterial diarrhea in persons with HIV infection, United States, 1992-2002.

Authors:  Travis H Sanchez; John T Brooks; Patrick S Sullivan; Marta Juhasz; Eric Mintz; Mark S Dworkin; Jeffrey L Jones
Journal:  Clin Infect Dis       Date:  2005-10-31       Impact factor: 9.079

4.  Clostridium difficile-associated diarrhea in HIV-infected patients: epidemiology and risk factors.

Authors:  F Barbut; J L Meynard; M Guiguet; V Avesani; M V Bochet; M C Meyohas; M Delmée; P Tilleul; J Frottier; J C Petit
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1997-11-01

5.  Albumin, length of stay, and proton pump inhibitors: key factors in Clostridium difficile-associated disease in nursing home patients.

Authors:  Farrah Ibrahim J Al-Tureihi; Ali Hassoun; Gisele Wolf-Klein; Henry Isenberg
Journal:  J Am Med Dir Assoc       Date:  2005 Mar-Apr       Impact factor: 4.669

6.  Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection.

Authors:  M Warny; J P Vaerman; V Avesani; M Delmée
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

7.  Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994-2005.

Authors:  Kate Buchacz; Rose K Baker; Anne C Moorman; James T Richardson; Kathleen C Wood; Scott D Holmberg; John T Brooks
Journal:  AIDS       Date:  2008-07-11       Impact factor: 4.177

Review 8.  Clostridium difficile and inflammatory bowel disease.

Authors:  Mazen Issa; Ashwin N Ananthakrishnan; David G Binion
Journal:  Inflamm Bowel Dis       Date:  2008-10       Impact factor: 5.325

9.  Clostridium difficile-associated diarrhea in heart transplant recipients: is hypogammaglobulinemia the answer?

Authors:  Patricia Muñoz; Maddalena Giannella; Luís Alcalá; Elisabeth Sarmiento; Juan Fernandez Yañez; Jesus Palomo; Pilar Catalán; Javier Carbone; Emilio Bouza
Journal:  J Heart Lung Transplant       Date:  2007-09       Impact factor: 10.247

10.  Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003.

Authors:  L Clifford McDonald; Maria Owings; Daniel B Jernigan
Journal:  Emerg Infect Dis       Date:  2006-03       Impact factor: 6.883

View more
  3 in total

Review 1.  Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects.

Authors:  Stefano Di Bella; Paolo Ascenzi; Steven Siarakas; Nicola Petrosillo; Alessandra di Masi
Journal:  Toxins (Basel)       Date:  2016-05-03       Impact factor: 4.546

2.  Risk factors for Clostridium difficile infection in HIV-infected patients.

Authors:  Hannah Imlay; Daniel Kaul; Krishna Rao
Journal:  SAGE Open Med       Date:  2016-12-14

3.  Characteristics of Clostridium difficile infection in patients hospitalized with myelodysplastic syndrome or acute myelogenous leukemia.

Authors:  Kamini Shah; Bryan F Curtin; Christopher Chu; Daniel Hwang; Mark H Flasar; Erik von Rosenvinge
Journal:  World J Clin Oncol       Date:  2017-10-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.